**Question:** A 35 year old female with a previous history of bih [bih: bihar] of a child with Down's syndrome, presents with 18 weeks Amenorrhoea. The Investigation of choice rule out Down's syndrome in the present pregnancy is:

A. Serum beta-hCG
B. Serum Alpha-fetoprotein (AFP)
C. Serum Inhibin-A
D. Amniocentesis

**Correct Answer:** D. Amniocentesis

**Core Concept:** Down syndrome is a genetic disorder caused by the presence of an extra chromosome 21. In the context of this question, we are discussing the management of a pregnant woman with a previous child with Down syndrome and presenting with 18 weeks amenorrhoea. The primary goal of the investigation is to rule out Down syndrome in the current pregnancy.

**Why the Correct Answer is Right:** Amniocentesis is the correct investigation to rule out Down syndrome in this scenario because it allows for the definitive diagnosis of chromosomal abnormalities, including trisomy 21 (Down syndrome). Amniocentesis involves obtaining a sample of amniotic fluid from the uterus during pregnancy to analyze the chromosomes of the fetus. This test can accurately determine the presence of Down syndrome, as well as other chromosomal abnormalities.

**Why Each Wrong Option is Incorrect:**

A. Serum beta-hCG (human chorionic gonadotropin): beta-hCG is a hormone produced by the placenta during pregnancy. While monitoring beta-hCG levels can be useful in some contexts, it is not a definitive test for Down syndrome. It is more relevant for assessing gestational age, assessing early pregnancy loss, and monitoring the course of some pregnancy-related conditions.

B. Serum Alpha-fetoprotein (AFP): AFP is a protein produced by the fetus and placenta. Measuring AFP levels in the mother's blood can indicate the presence of specific fetal anomalies, including neural tube defects and Down syndrome. However, AFP is not specific for Down syndrome diagnosis alone.

C. Serum Inhibin-A: Inhibin-A is a hormone produced by the placenta and is involved in regulating follicle-stimulating hormone (FSH) and luteinizing hormone (LH) in the mother's blood. Inhibin-A measurement is not specific for the diagnosis of Down syndrome.

D. **Amniocentesis**: Amniocentesis is the correct investigation for Down syndrome diagnosis, as discussed above. It allows for the definitive diagnosis of chromosomal abnormalities, including Down syndrome.

**Clinical Pearls:**

1. While measuring serum beta-hCG and AFP can provide valuable information about the pregnancy and potential fetal anomalies, they are not the primary diagnostic tools for Down syndrome.
2. Amniocentesis is the definitive test for Down syndrome diagnosis, as it allows for the analysis of fetal chromosomes and other factors related to chromosomal abnormalities.
3. Inhibin-A is not specific for the diagnosis of Down syndrome.
4. Down syndrome is a chromosomal disorder that occurs